Skip to main content
. 2017 Nov 29;9:731–739. doi: 10.2147/CMAR.S148199

Table S1.

Exposure results summary

Treatment Min 25th percentile Median Mean 75th percentile Max
Everolimus, µg×h/L1
 Study results 32.6 42.3 130.7 137.7 229.9 310.1
 Clinical trial results 55 127 130 260
Axitinib, ng×h/mL6
 Study results 61.0 238.7 268.3 264.4 303.0 430.0
 Clinical trial results 32.8 375 NR 1728

Abbreviations: Max, maximum; Min, minimum; NR, not reported.